Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
10,876,096
-
Total 13F shares
-
540,643
-
Share change
-
+540,622
-
Total reported value
-
$1,211,205
-
Price per share
-
$2.24
-
Number of holders
-
17
-
Value change
-
+$1,211,159
-
Number of buys
-
16
Institutional Holders of AYTU BIOPHARMA, INC - Common Stock (AYTU) as of Q1 2023
As of 31 Mar 2023,
AYTU BIOPHARMA, INC - Common Stock (AYTU) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
540,643 shares.
The largest 10 holders included
Nantahala Capital Management, LLC, Alyeska Investment Group, L.P., RENAISSANCE TECHNOLOGIES LLC, DIMENSIONAL FUND ADVISORS LP, BlackRock Inc., ACADIAN ASSET MANAGEMENT LLC, COMMONWEALTH EQUITY SERVICES, LLC, PRUDENTIAL FINANCIAL INC, GEODE CAPITAL MANAGEMENT, LLC, and UBS Group AG.
This page lists
17
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.